Results 281 to 290 of about 457,294 (313)

Nausea and vomiting of pregnancy and hyperemesis gravidarum

Nature Reviews Disease Primers, 2019
Marlena S Fejzo, Jone Trovik, Iris J Grooten   +2 more
exaly  

Consensus Guidelines for the Management of Postoperative Nausea and Vomiting

Anesthesia and Analgesia, 2014
Tong J Gan, Ashraf S Habib, Anthony L Kovac   +2 more
exaly  

The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group

Journal of Clinical Oncology, 2003
Richard J Gralla, Fausto Roila, Alexandra D Carides   +2 more
exaly  

PSYCHOGENIC VOMITING*

The Journal of Nervous and Mental Disease, 1946
openaire   +2 more sources

Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer After Moderately Emetogenic Chemotherapy

Journal of Clinical Oncology, 2005
Richard J Gralla, Anthony Rodgers
exaly  

Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial

Lancet Oncology, The, 2009
Hiroshi Sakai
exaly  

Evidence for a Re-Evaluation of the Neurochemical and Anatomical Bases of Chemotherapy-Induced Vomiting

Chemical Reviews, 2009
Nissar A Darmani
exaly  

Erotic vomiting

Archives of Sexual Behavior, 1982
openaire   +2 more sources

Prevention and Treatment of Postoperative Nausea and Vomiting

Drugs, 2012
Anthony L Kovac
exaly  

Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer: two randomised, active-controlled, double-blind, phase 3 trials

Lancet Oncology, The, 2015
Lee S Schwartzberg, Rudolph M Navari
exaly